Concentra Group Holdings Parent Inc. (NYSE:CON) is one of the best new stocks to buy right now. On September 18, JPMorgan analyst Benjamin Rossi assumed coverage of Concentra with an Overweight rating and unchanged price target of $31. JPMorgan believes that the current outpatient environment is most favorable for companies with lower reimbursement exposure to federal funding.

Earlier in Q2 2025, Concentra Group ended the quarter with total revenue growth of 15.2% year-over-year. Excluding contributions from the Nova acquisition, the revenue growth was 15.2%. The company’s focus on growth through acquisition and internal development continued. Concentra Group completed the integration and rebranding of Nova occupational health centers and opened an additional de novo site in Chattanooga, Tennessee.

Furthermore, the acquisition of Pivot On-site Health Clinics was completed, which doubled the size of their on-site health clinic segment. The total on-site clinic count is now 240, which is expected to contribute approximately $120 million in revenue for 2025. The company also expanded its board of directors with experienced professionals to contribute to future success. Concentra Group raised its 2025 revenue guidance to a range of $2.13 to $2.16 billion.

Concentra Group Holdings Parent Inc. (NYSE:CON) provides occupational health services in the US. The company offers workers’ compensation, employer & consumer health services, and employer-sponsored primary care services.

While we acknowledge the potential of CON as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.